SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-126021
Filing Date
2023-12-14
Accepted
2023-12-14 16:01:36
Documents
18
Period of Report
2023-12-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332663d1_8k.htm   iXBRL 8-K 28167
2 EXHIBIT 99.1 tm2332663d1_ex99-1.htm EX-99.1 13995
3 EXHIBIT 99.2 tm2332663d1_ex99-2.htm EX-99.2 16824
7 GRAPHIC tm2332663d1_ex99-1img001.jpg GRAPHIC 5019
8 GRAPHIC tm2332663d1_ex99-1img002.jpg GRAPHIC 5036
9 GRAPHIC tm2332663d1_ex99-1img003.jpg GRAPHIC 5126
10 GRAPHIC tm2332663d1_ex99-2img001.jpg GRAPHIC 4150
  Complete submission text file 0001104659-23-126021.txt   272330

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20231213.xsd EX-101.SCH 3024
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20231213_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20231213_pre.xml EX-101.PRE 22365
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2332663d1_8k_htm.xml XML 3311
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 231487048
SIC: 2834 Pharmaceutical Preparations